Reflecting on our partnership with The BioIndustry Association
As we come to the end of our time as the BioIndustry Association’s Charity of the year, we have been reflecting on what a fantastic opportunity it has been for us.
Ovarian Cancer Action is working towards a world where no woman dies of ovarian cancer. One woman dies in the UK from ovarian cancer every two hours and although five-year survival rates for ovarian cancer are improving, other cancers, such as breast cancer, had better survival rates two generations ago than ovarian cancer does today. We want to improve survival rates through funding high quality research and including the patient voice in everything we do.
We were inspired by how the BIA brought the biotech and bioprocessing industries together during the pandemic to help develop vaccines over the last year and a half. Fostering a space for collaboration and accelerated innovation on an international scale has inspired us in what could be achieved in the ovarian cancer research field.
Over the year we’ve developed close relationships with the leading biotechs working in ovarian cancer, and we are privileged that we have been given this opportunity to create new connections and learn more about this field. We know these connections will help to accelerate our work to improve outcomes for women affected by ovarian cancer, and ensure new treatments are developed quickly to reach patients as soon as possible.
Throughout May, we called on BIA members to participate in our Research Relay to help raise money for crucial research to find more effective treatments for ovarian cancer. We want to say a massive thank you to all the teams who took part, helping to raise £22,000 for OCA. We are so grateful for all of your hard work. We were able to present awards to the winning teams who raised the most money at the BIA Summer Party back in September, our first in person event in a year and a half, including the top team MedAnnex.
Maximising the impact of our research
Cary Wakefield, CEO of Ovarian Cancer Action said “A woman in the UK dies of ovarian cancer every two hours. It is an incredibly complex disease with shockingly low survival rates but we are committed to changing this for women affected, now and in the future. Reflecting over the last year, our partnership with the BIA has not only helped to raise money towards vital research to help more women survive ovarian cancer, but has opened doors to maximise the impact of our research over the next five years. We are so grateful for this experience and we look forward to continuing a relationship with BIA and its members. Together, we can work towards a future where every woman survives ovarian cancer”.
We want to say a massive thank you to the BIA for all their support over the last year, and we look forward to continuing our relationship in the future.
Walk in Her Name 100km in MarchWalk In Her Name in 2022 about Walk in Her Name 100km in March
March is Ovarian Cancer Awareness Month, join our Step Challenge and walk 100km to fund life-saving research. Together we can help more women survive ovarian cancer.
What has happened with our research this year?Find out more about What has happened with our research this year?
Your support funds vital ovarian cancer research. Learn all about the incredible work that our scientists have been working on in 2022 to help prevent ovarian cancer, diagnose it early and develop effective, personalised treatments.
Meet our ScientistsFind out more about Meet our Scientists
Get to know the incredible individuals behind the work we fund. Our researchers are based across the UK at the Ovarian Cancer Action Research Centre, University of Oxford and beyond, and they're working tirelessly to change the future for women with ovarian cancer.